|
|
||||||||
Department of Physiology, Monash University, Melbourne, Victoria 3800, Australia
| |
ABSTRACT |
|---|
|
|
|---|
Glycyrrhetinic acid (GA)
derivatives have been used to implicate gap junctions in vasorelaxation
attributed to endothelium-derived hyperpolarizing factor (EDHF). The
aim of this study was to assess whether GA compounds affect endothelial
cell hyperpolarization. Membrane potentials were recorded from
dye-identified endothelial and smooth muscle cells of guinea pig
coronary and rat mesenteric arteries. GA derivatives had varied effects
on the resting membrane potential: depolarization, hyperpolarization,
or no effect, depending on the artery. 18
-GA (50 µM) had a small
variable effect on ACh-induced hyperpolarizations in endothelial cells.
18
-GA (30 µM) and carbenoxolone (100 µM) significantly reduced
ACh-induced hyperpolarizations in both endothelial and smooth muscle
cells. Smooth muscle action potentials in rat tail arteries were
smaller and slower in the presence of 18
-GA. Nerve-induced
excitatory junction potentials were inhibited by 18
-GA and
carbenoxolone, whereas the time course of their decay initially
increased and then decreased. In conclusion, the GA compounds had a
range of effects. Their inhibition of the EDHF hyperpolarization and
relaxation in the smooth muscle may stem from the inhibition of
endothelial cell hyperpolarization.
gap junctions; glycyrrhetinic acid; action potentials; carbenoxolone; endothelium-derived hyperpolarizing factor
| |
INTRODUCTION |
|---|
|
|
|---|
AN INCREASING APPRECIATION of the importance of gap junction intercellular communication (GJIC) in diverse tissues is resulting in greater interest in agents that can alter the activity of gap junctions. In some blood vessels, the endothelial and smooth muscle cells are electrically (2, 5, 6, 9, 16, 26, 27) or dye coupled (15), and this has raised the possibility that, at least in some blood vessels, endothelium-dependent hyperpolarization in vascular smooth muscle may represent electrotonic spread, via myoendothelial gap junctions, of hyperpolarization generated in the endothelial cells (3). Inhibitors of GJIC would be invaluable tools with which to assess the involvement of GJIC in the prominent smooth muscle hyperpolarization that is independent of nitric oxide and prostanoid and attributed to endothelium-derived hyperpolarizing factor (EDHF). Although there are a number of putative inhibitors of gap junctions, nonspecific actions limit their usefulness.
Glycyrrhetinic acid (GA) and its derivatives are triterpenoid saponins derived from licorice. These agents inhibit intercellular transfer of metabolites, and this has been attributed to the inhibition of gap junctions (7). GA also inhibits the spread of the fluorescent dye Lucifer yellow between alveolar epithelial cells (11). On the basis of these effects of GA on GJIC, some studies (8, 28, 29) using GA derivatives have concluded that EDHF is due to electrotonic spread. However, even though smooth muscle cells are coupled electrically, Lucifer yellow does not move from smooth muscle cells either to neighboring smooth muscle or into endothelial cells (5, 6, 9, 15, 23). Therefore, inhibition of dye coupling may not necessarily mean that electrical activity is uncoupled. Furthermore, GA derivatives have been reported to have a range of effects, and this is not surprising in view of the detergent-like nature of these compounds. A reputed inhibition of arachidonic acid metabolism (14) is particularly pertinent to EDHF because there have been suggestions that EDHF may be a product of the cytochrome P-450 pathway of arachidonic acid metabolism in some vessels (4, 10, 18). The aim of the present study was to evaluate the effects of GA compounds on the ACh-induced hyperpolarization recorded from identified endothelial cells. The study focused on the guinea pig coronary artery because stimulation of its endothelium in the presence of nitric oxide and prostaglandin synthesis inhibitors results in a very pronounced hyperpolarization of the smooth muscle that is attributed to EDHF (13, 17, 24). The results of the present study indicate that GA derivatives have a range of effects that limit their usefulness in evaluating the involvement of electrical coupling in cellular processes, especially in the actions of EDHF.
| |
METHODS |
|---|
|
|
|---|
Guinea pigs and rats were killed by cervical dislocation with
ethics committee approval. For membrane potential recordings from
endothelial cells, guinea pig coronary and rat mesenteric arteries were
cut open and secured to the Silicone rubber floor of the recording
chamber with the endothelium uppermost. In other experiments, ring
segments of guinea pig coronary and rat tail arteries, 1-2 mm in
length, were mounted on a wire myograph for simultaneous measurement of
smooth muscle membrane potential and isometric tension (17,
24). Silver-silver chloride electrodes mounted on the jaws of
the myograph, one on either side of the tissue, were used to stimulate
the perivascular sympathetic nerves of the rat tail artery. Pulse
strengths of 20-40 V (stimulator dial settings) and 0.1 ms in
duration were used. Responses evoked by electrical stimulation were
sensitive to tetrodotoxin. Tissues were superfused at 3.6 ml/min and
35°C with physiological saline solution (PSS) consisting of (in mM)
120 NaCl, 5 KCl, 25 NaHCO3, 1 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, and 11 glucose and bubbled with 95%
O2-5% CO2. Except where indicated,
N
-nitro-L-arginine methyl ester
(L-NAME; 100 µM) and indomethacin (1 µM) were included
in the superfusate to inhibit nitric oxide and prostaglandin
production. The endothelium was stimulated with ACh using two methods
of application: for short exposures, ACh was injected directly into the
superfusion line for 10 s; for long exposures, ACh was added to
the superfusate for 1 min.
Membrane potentials were recorded with intracellular glass
microelectrodes. The tips of the electrodes were initially filled with
2% Lucifer yellow CH as the dilithium salt dissolved in 1 M LiCl, and
the electrodes were then backfilled with 1 M KCl, resulting in
electrode resistances of ~100 M
. Diffusion of the Lucifer yellow
into the cells from which the recordings were made enabled the
unequivocal identification of the cells when viewed with
epifluorescence optics. Every endothelial cell studied was identified
in this manner.
The following drugs were used: ACh, L-NAME, indomethacin,
dilithium Lucifer yellow CH, phenylephrine, 18
-GA, 18
-GA,
carbenoxolone, tetraethylammonium (all from Sigma), and U46619 (Cayman
Chemicals). Stock solutions of 18
-GA and 18
-GA were prepared
immediately before use to minimize possible cytotoxicity of these
compounds (7). 18
-GA and 18
-GA were dissolved in
dimethyl sulfoxide (BDH Chemicals), which was without effect at 100 µM. Carbenoxolone was dissolved directly in the PSS.
Data were compared using Student's t-test, paired or unpaired as appropriate, using the software packages InStat3 or Prism3 (both from GraphPad). P values <0.05 were considered statistically significant. Means ± SE and the number of animals (n) are quoted throughout. Concentration-response data for each tissue were fitted to a sigmoidal curve using the least-squares method (Prism3). The time constant of decay of excitatory junction potentials (EJPs) was determined by fitting a single exponential to the decay of the EJPs using the software CLAMPfit 8 (Axon Instruments).
| |
RESULTS |
|---|
|
|
|---|
Identification of cell types.
An important aspect to this study was the unequivocal identification of
the type of cell from which the recordings were made. Figure
1, left, shows an endothelial
cell that was identified under epifluorescence optics after its loading
with Lucifer yellow. These cells were orientated along the longitudinal
axis of the arteries. Smooth muscle cells loaded with Lucifer yellow
were identified by their transverse orientation to the vessel axis (Fig. 1, right).
|
Guinea pig coronary artery smooth muscle.
The effects of 18
-GA, 18
-GA, and carbenoxolone on the EDHF
hyperpolarization were examined in recordings of membrane potential made from the smooth muscle of coronary arteries mostly mounted on a
wire myograph and superfused with PSS containing L-NAME and indomethacin. The resting membrane potential of coronary artery smooth muscle cells in arteries mounted on the myograph was
52 ± 3 mV (n = 8). In tissues at rest, 18
-GA (30 µM)
evoked an initial hyperpolarization of 8 ± 3 mV
(n = 4), but this tended to decrease over time.
18
-GA decreased the amplitude of the hyperpolarization evoked by
1-min exposure to 0.1 µM ACh from 14 ± 1 to 5 ± 1 mV (n = 4, P = 0.0017). An example of a
response recorded from a smooth muscle cell in a tissue pinned out flat
is shown in Fig. 2A,a. From
concentration-response curves for 10-s applications of ACh, 18
-GA
reduced the pD2 from 7.23 ± 0.07 to 6.87 ± 0.16 (n = 4), but these were not significant
(P = 0.085) (Fig. 2C,c).
|
-GA (50 µM) had no significant effect on either the resting
membrane potential or on the hyperpolarization evoked by ACh (Fig.
3B, bottom).
|
Guinea pig coronary artery endothelial cells.
Because the EDHF-attributed hyperpolarization may well be due to
electrotonic spread of hyperpolarization from the endothelium, the
effects of the GA compounds were assessed on dye-identified (Lucifer
yellow) endothelial cells in coronary arteries. L-NAME and
indomethacin were present in the PSS throughout the experiments. 18
-GA hyperpolarized the membrane from
41 ± 1 to
44 ± 2 mV (n = 5) and decreased the amplitude of the
hyperpolarization evoked by ACh (1 min) from 16 ± 1 mV to 6 ± 1 mV (n = 5, P = 0.0001) within 6 min (Fig. 2, A,a, and B).
48 ± 4 to
34 ± 2 mV (n = 5).
Carbenoxolone also reduced the ACh (1 min)-induced hyperpolarization,
from 17 ± 2 to 4 ± 1 mV (n = 5, P = 0.0004) within 6 min (Fig. 2,
A,b, and B).
18
-GA (50 µM) had no significant effect on the resting membrane
potential. It had a small and variable effect, which declined after 30 min, on the hyperpolarization evoked by ACh (Fig. 3, A and
B, top).
Rat mesenteric artery endothelial cells.
The EDHF hyperpolarization of the rat mesenteric artery has been the
subject of a number of studies, including one study (8) in
which carbenoxolone reduced the smooth muscle hyperpolarization. In the
present study, we recorded the effects of carbenoxolone on the
ACh-induced hyperpolarization of dye-identified endothelial cells in
this artery. Carbenoxolone (100 µM) had a small, variable, and
insignificant effect on the resting potential (
59 ± 1 mV in
control and
55 ± 6 mV in carbenoxolone, n = 3).
However, it reduced the amplitude of the hyperpolarization induced by
1-min application of 0.1 µM ACh from 18 ± 2 to 7 ± 2 mV
(n = 3, P = 0.0177) (Fig. 2,
A,c, and B).
Rat tail artery junction and action potentials.
EJPs and action potentials can be readily and consistently evoked in
the rat tail artery. The resting membrane potential of smooth muscle
cells of the rat tail artery was
67 ± 1 mV (n = 10). In this vessel, 18
-GA (30 or 50 µM) evoked 7.0 ± 1.2 mV (n = 6) depolarization of the membrane and decreased
the amplitude of subthreshold EJPs from 4.1 ± 0.3 mV (77 EJPs,
n = 5) to 2.5 ± 0.2 mV (75 EJPs,
n = 5, P < 0.001) (Fig.
4A). 18
-GA had a biphasic effect on the time constant of decay of the EJPs, with an initial increase and then a decrease (Fig. 4B).
|
-GA (50 µM) decreased the
amplitude of the action potentials from 46.7 ± 1.0 mV
(n = 9) to 29.3 ± 0.5 mV (n = 7, P < 0.0001), often with a shoulder appearing on the
repolarization phase (Fig. 4C) (L-NAME and
indomethacin were present on 4 of 9 or 7 occasions and had no
additional effects). In contrast, carbenoxolone (100 µM) had no
effect on the amplitude of the action potentials (47.4 ± 0.8 mV,
n = 5) (Fig. 4C).
In another set of experiments, brief (30 s) applications of
phenylephrine (1 µM) were used to depolarize and evoke action potentials and contract the rat tail artery (in the presence of 2 mM
tetraethylammonium). 18
-GA (30 µM) reduced the
phenylephrine-induced depolarization, the action potentials, and
contraction (Fig. 5). In contrast,
carbenoxolone (100 µM) had no obvious effect on any of these
responses (Fig. 5) (4 tissues studied; 2 included L-NAME and indomethacin).
|
| |
DISCUSSION |
|---|
|
|
|---|
A striking feature of the results presented in this study is the similarity in recordings made from identified endothelial cells with recordings from identified smooth muscle cells. The membrane potentials before, as well as during, the hyperpolarizations induced by ACh were very similar in both cell layers in the guinea pig coronary artery in both the absence and presence of GA compounds (e.g., Fig. 2A). Such observations are consistent with strong electrical coupling between the two layers of cells, as indicated in a number of other blood vessels (2, 5, 6, 9, 16, 26). The persistent similarity in the responses in the presence of GA compounds indicate that the effects of the three GA compounds on electrical coupling between the two layers of cells in the guinea pig coronary artery are likely to be weak. These results support the notion that the inhibitory actions of GA compounds on the EDHF-attributed hyperpolarization and relaxation of vascular smooth muscle cells (Ref. 8 and the present study) are due to their inhibition of the responses of endothelial cells to agonist stimulation.
In the rat mesenteric artery the reduction by carbenoxolone of the endothelial hyperpolarization to 39% (present study) is reasonably similar to the inhibition of smooth muscle hyperpolarization (to 56%) reported by Edwards et al. (8). Thus these observations on the rat mesenteric artery are also consistent with strong electrical coupling, the electron microscopic evidence of myoendothelial gap junctions in this artery (20), and with the GA compounds not appreciably affecting the electrical coupling.
In inhibiting the initiation of the EDHF-attributed hyperpolarization,
there are a number of sites at which the GA compounds could act, of
which some may involve the smooth muscle cells. Inhibition of
muscarinic receptors may be unlikely because binding studies have ruled
out an effect of carbenoxolone on a wide range of receptors including
muscarinic receptors (19). Phospholipase activity has been
implicated in the production and/or actions of EDHF (1),
and phospholipase activity has been reported to be inhibited by GA
compounds (14). Furthermore, inhibition of the activation
or activity of intermediate and small conductance Ca2+-activated K+ channels, which underlie the
EDHF-attributed hyperpolarization (6), could explain its
reduced amplitude. This is a real possibility because action potentials
initiated by nerve stimulation or phenylephrine were of smaller
amplitude and slower time course in the presence of 18
-GA (although
not carbenoxolone), indicating an inhibitory effect of this GA compound
on voltage-operated Ca2+ channels. This observation is
consistent with, and extends the conclusions of, Santicioli and Maggi
(21), who showed that 18
-GA (30 µM) inhibited
electrical and contractile activity of the guinea pig renal pelvis and
ureter. The sucrose gap technique used in that study could not
distinguish between an effect on electrical coupling or an effect on
the action potentials. Our results strongly support the latter and not
the former possibility. At 100 µM, 18
-GA was found to have
nonspecific effects that limited its usefulness in determining the
involvement of gap junctions (21).
The GA compounds (18
-GA in particular) also decreased the amplitude
of the EJPs and, after a transient increase, resulted in a marked
decline in the decay time constant of the EJPs, the latter being
indicative of a decrease in membrane resistance. The transient increase
in the decay of the EJPs may have resulted from an inhibition of ion
transport processes that contribute to the resting conductance, and
this would be consistent with the changes in the resting membrane
potential. The subsequent decrease in membrane resistance may well be
an increase in membrane leakiness due to the detergent-like nature of
these triterpenoid saponins. Although the decrease in membrane
resistance may explain some of the decrease in the amplitude of the
EJPs, the decline in the amplitudes preceded the decline in the decay
time constant of the EJPs. There are myriad steps between the
initiation of the presynaptic action potential and the EJP at which the
GA compounds could exert their effects.
The GA compounds that were used in the present study were also capable
of inducing changes in the resting membrane potential of the smooth
muscle and endothelial cells. The effects on the resting potential
depended on the particular compound and on the blood vessel, but in any
individual vessel the effects on the endothelial and smooth muscle
cells were similar. Thus 18
-GA tended to hyperpolarize the smooth
muscle and endothelial cells of the guinea pig coronary artery, whereas
carbenoxolone depolarized both cell layers. In contrast, in the rat
tail artery, 18
-GA depolarized the membrane, and carbenoxolone had a
small biphasic effect. In guinea pig submucosal arterioles, 18
-GA
and carbenoxolone both produced large depolarizations of the membrane
(6, 12). GA-induced depolarization may be due, at least in
part, to inhibition of Na+-K+-ATPase
(25). The reasons for the differences in the effects of
the GA compounds between blood vessels are not clear but may reflect
different complements of ion transport processes.
Carbenoxolone (18
-GA, 3
-O-hemisuccinate) is a more
water-soluble form of 18
-GA and has been presumed to have similar
effects to 18
-GA. Both agents inhibited the ACh-induced
hyperpolarization in endothelial and smooth muscle cells and also
reduced the amplitude of the EJPs. However, in the present study, there
were some differences between the two. 18
-GA had an inhibitory
effect on the smooth muscle action potential, whereas carbenoxolone did
not. In the guinea pig coronary smooth muscle cells, 18
-GA evoked
hyperpolarization, whereas carbenoxolone depolarized the cells. The
reasons for the different effects are not clear but may reflect
differences in their lipophilic nature.
That carbenoxolone inhibited the ACh-induced hyperpolarization in guinea pig coronary artery endothelial cells that were unequivocally identified with Lucifer yellow is at variance with previous reports of carbenoxolone having no effect on the ACh-induced hyperpolarization of endothelial cells in the guinea pig carotid artery (8). The reason for this discrepancy is not clear but may reflect variability between tissues.
Some evidence indicates that the
-form of GA (18
-GA) is a more
specific and less toxic inhibitor of gap junctions than other GA
compounds (7). In the present study, 18
-GA was less
effective than either 18
-GA or carbenoxolone, consistent with an
ineffectiveness of 18
-GA on myoendothelial coupling in the rat
mesenteric artery (22). It had only a small and variable
effect on the ACh-induced hyperpolarization of endothelial cells, which
did not persist beyond 30 min, and no appreciable effect on the
hyperpolarization recorded from smooth muscle cells. A small difference
in effect between the two cell types also occurred with the other two
GA compounds when the smooth muscle recordings were made from tissues mounted on the wire myograph. This difference in effect may reflect differences in accessibility of the GA compounds to the endothelial cell layer, and this depended on the experimental setup that was used.
During recordings from the endothelial cells, the superfusate flowed
directly over the exposed endothelial cells, whereas during recordings
from the smooth muscle cells in arteries mounted on the wire myograph,
the endothelial cells were less directly exposed to the superfusate,
remaining in the very limited "lumen" of the wire myograph
preparation. If the hyperpolarizations attributed to EDHF were
generated in the endothelial cells, then reduced accessibility to the
endothelial cells could result in a lesser effect of the GA compounds.
Nevertheless, that the hyperpolarizations recorded from the smooth
muscle and endothelial cells were of similar amplitude suggests that
18
-GA, similar to 18
-GA or carbenoxolone, had no appreciable
effects on electrical coupling between the two cell layers.
The effectiveness of various putative gap junction inhibitors, including GA compounds, has been assessed in dye transfer studies, usually with the fluorescent dye Lucifer yellow. In the present study, Lucifer yellow rapidly spread from the impaled endothelial cell to neighboring cells. Dye localization in the impaled cell persisted after removal of the GA compounds even though endothelial and smooth muscle hyperpolarization returned to normal. This is consistent with the notion that inhibition of dye transfer may not be a good indicator of the state of electrical coupling. Good electrical coupling of smooth muscle cells has been shown to occur in the absence of dye coupling (9, 23). It is possible that good electrical coupling between the two cell layers may require the patency of only a small proportion of the total number of connexons present.
In conclusion, these results show that GA compounds can exert a variety of effects, some of which are likely to alter the activity of ion transport processes, including ion channels. The various effects of the GA compounds raise concerns regarding the interpretation of results that are based on the assumption that the only effect of these agents is to inhibit GJIC. In particular, the inhibition by these compounds of hyperpolarization induced in endothelial cells by ACh indicates that these agents are limited in their usefulness in the evaluation of the involvement of electrical coupling in the EDHF-attributed hyperpolarization and relaxation of smooth muscle in blood vessels.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by the National Health and Medical Research Council of Australia. This work was carried out during the tenure of a grant from the National Heart Foundation.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: H. A. Coleman, Dept. of Physiology, PO Box 13F, Monash Univ., Melbourne, Victoria 3800, Australia (E-mail: h.coleman{at}med.monash.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6 June 2001; accepted in final form 17 September 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adeagbo, ASO,
and
Henzel MK.
Calcium-dependent phospholipase A2 mediates the production of endothelium-derived hyperpolarizing factor in perfused rat mesenteric prearteriolar bed.
J Vasc Res
35:
27-35,
1998[ISI][Medline].
2.
Bény, J-L.
Electrical coupling between smooth muscle cells and endothelial cells in pig coronary arteries.
Pflügers Arch
433:
364-367,
1997[ISI][Medline].
3.
Bény, J-L.
Information networks in the arterial wall.
News Physiol Sci
14:
68-73,
1999
4.
Campbell, WB,
Gebremedhin D,
Pratt PF,
and
Harder DR.
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.
Circ Res
78:
415-423,
1996
5.
Coleman, HA,
Tare M,
and
Parkington HC.
EDHF is not K+ but may be due to spread of current from the endothelium in guinea pig arterioles.
Am J Physiol Heart Circ Physiol
280:
H2478-H2483,
2001
6.
Coleman, HA,
Tare M,
and
Parkington HC.
K+ currents underlying the action of endothelium-derived hyperpolarizing factor in guinea-pig, rat and human blood vessels.
J Physiol (Lond)
531:
359-373,
2001
7.
Davidson, JS,
and
Baumgarten IM.
Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships.
J Pharmacol Exp Ther
246:
1104-1107,
1988
8.
Edwards, G,
Félétou M,
Gardener MJ,
Thollon C,
Vanhoutte PM,
and
Weston AH.
Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries.
Br J Pharmacol
128:
1788-1794,
1999[ISI][Medline].
9.
Emerson, GG,
and
Segal SS.
Endothelial cell pathway for conduction of hyperpolarization and vasodilation along hamster feed artery.
Circ Res
86:
94-100,
2000
10.
Fisslthaler, B,
Popp R,
Kiss L,
Potente M,
Harder DR,
Fleming I,
and
Busse R.
Cytochrome P450 2C is an EDHF synthase in coronary arteries.
Nature
401:
493-497,
1999[Medline].
11.
Guo, Y,
Martinez-Williams C,
Gilbert KA,
and
Rannels DE.
Inhibition of gap junction communication in alveolar epithelial cells by 18
-glycyrrhetinic acid.
Am J Physiol Lung Cell Mol Physiol
276:
L1018-L1026,
1999
12.
Imaeda, K,
Yamamoto Y,
Fukuta H,
Koshita M,
and
Suzuki H.
Hyperpolarization-induced dilatation of submucosal arterioles in the guinea-pig ileum.
Br J Pharmacol
131:
1121-1128,
2000[ISI][Medline].
13.
Keef, KD,
and
Bowen SM.
Effect of ACh on electrical and mechanical activity in guinea pig coronary arteries.
Am J Physiol Heart Circ Physiol
257:
H1096-H1103,
1989
14.
Kelloff, GJ,
Boone CW,
Steele VE,
Fay JR,
Lubet RA,
Crowell JA,
and
Sigman CC.
Mechanistic considerations in chemopreventive drug development.
J Cell Biochem Suppl
20:
1-24,
1994[Medline].
15.
Little, TL,
Xia J,
and
Duling BR.
Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall.
Circ Res
76:
498-504,
1995
16.
Marchenko, SM,
and
Sage SO.
Smooth muscle cells affect endothelial membrane potential in rat aorta.
Am J Physiol Heart Circ Physiol
267:
H804-H811,
1994
17.
Parkington, HC,
Tonta MA,
Coleman HA,
and
Tare M.
Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle.
J Physiol (Lond)
484:
469-480,
1995[ISI][Medline].
18.
Popp, R,
Bauersachs J,
Hecker M,
Fleming I,
and
Busse R.
A transferable,
-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.
J Physiol (Lond)
497:
699-709,
1996[ISI][Medline].
19.
Quignard, JF,
Félétou M,
Edwards G,
Duhault J,
Weston AH,
and
Vanhoutte PM.
Role of endothelial cell hyperpolarization in EDHF-mediated responses in the guinea-pig carotid artery.
Br J Pharmacol
129:
1103-1112,
2000[ISI][Medline].
20.
Sandow, SL,
and
Hill CE.
Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses.
Circ Res
86:
341-346,
2000
21.
Santicioli, P,
and
Maggi CA.
Effect of 18
-glycyrrhetinic acid on electromechanical coupling in the guinea-pig renal pelvis and ureter.
Br J Pharmacol
129:
163-169,
2000[ISI][Medline].
22.
Schuster, A,
Oishi H,
Bény JL,
Stergiopulos N,
and
Meister JJ.
Simultaneous arterial calcium dynamics and diameter measurements: application to myoendothelial communication.
Am J Physiol Heart Circ Physiol
280:
H1088-H1096,
2001
23.
Segal, SS,
and
Bény J-L.
Intracellular recording and dye transfer in arterioles during blood flow control.
Am J Physiol Heart Circ Physiol
263:
H1-H7,
1992
24.
Tare, M,
Parkington HC,
and
Coleman HA.
EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries.
Br J Pharmacol
130:
605-618,
2000[ISI][Medline].
25.
Terasawa, T,
Okada T,
Hara T,
and
Itoh K.
Glycyrrhetinic acid derivatives as potent inhibitors of Na+,K+-ATPase. Synthesis and structure-activity relationships.
Eur J Med Chem
27:
345-351,
1992.
26.
Von der Weid, P-Y,
and
Bény J-L.
Simultaneous oscillations in the membrane potential of pig coronary artery endothelial and smooth muscle cells.
J Physiol (Lond)
471:
13-24,
1993
27.
Xia, J,
Little TL,
and
Duling BR.
Cellular pathways of the conducted electrical response in arterioles of hamster cheek pouch in vitro.
Am J Physiol Heart Circ Physiol
269:
H2031-H2038,
1995
28.
Yamamoto, Y,
Fukuta H,
Nakahira Y,
and
Suzuki H.
Blockade by 18
-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles.
J Physiol (Lond)
511:
501-508,
1998
29.
Yamamoto, Y,
Imaeda K,
and
Suzuki H.
Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles.
J Physiol (Lond)
514:
505-513,
1999
This article has been cited by other articles:
![]() |
A. Makino, O. Platoshyn, J. Suarez, J. X.-J. Yuan, and W. H. Dillmann Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice Am J Physiol Cell Physiol, July 1, 2008; 295(1): C221 - C230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takenaka, T. Inoue, Y. Kanno, H. Okada, C. E. Hill, and H. Suzuki Connexins 37 and 40 transduce purinergic signals mediating renal autoregulation Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R1 - R11. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Haddock, T. H. Grayson, T. D. Brackenbury, K. R. Meaney, C. B. Neylon, S. L. Sandow, and C. E. Hill Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connexins 37 and 40 Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2047 - H2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Matchkov, A. Rahman, L. M. Bakker, T. M. Griffith, H. Nilsson, and C. Aalkjaer Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H357 - H367. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mather, K. A. Dora, S. L. Sandow, P. Winter, and C. J. Garland Rapid Endothelial Cell-Selective Loading of Connexin 40 Antibody Blocks Endothelium-Derived Hyperpolarizing Factor Dilation in Rat Small Mesenteric Arteries Circ. Res., August 19, 2005; 97(4): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E Haddock and C. E Hill Rhythmicity in arterial smooth muscle J. Physiol., August 1, 2005; 566(3): 645 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeda, S. M. Ward, K. M. Sanders, and S. D. Koh Effects of the gap junction blocker glycyrrhetinic acid on gastrointestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G832 - G841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. C. Resta, and B. R. Walker Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2677 - H2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Poelzing and D. S. Rosenbaum Altered connexin43 expression produces arrhythmia substrate in heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1762 - H1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kansui, K. Fujii, K. Nakamura, K. Goto, H. Oniki, I. Abe, Y. Shibata, and M. Iida Angiotensin II receptor blockade corrects altered expression of gap junctions in vascular endothelial cells from hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H216 - H224. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morio, E. P. Carter, M. Oka, and I. F. McMurtry EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1762 - H1770. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |